NKG2D |
1HQ8, 1HYR (NKG2D/MICA), 1KCG (NKG2D/ULBP3), 1JSK (NKG2D/Rae-1β) |
MICA/B, ULBP1-6 |
DAP10 |
HCMV, KSV, HBV, HIV- 1, IV |
126, 128, 129, 162–165
|
NKG2C- CD94 |
2L35 (DAP12/NKG2C) |
HLA-E |
DAP12 |
HCMV, HBV, HCV, hantavirus |
112, 120, 122, 142, 166, 167, |
NKp46 (NCR1) |
1P6F, 1OLL |
HA, heparan sulfate/ heparin |
FcεRIγ, CD3ζ |
Influenza, vaccinia, HCV, HSV, NDV, SeV |
14, 139–143, 146–148, 153
|
NKp44 (NCR2) |
1HKF |
HA, heparan sulfate/ heparin, E- protein, PCNA, bacterial cell wall elements |
DAP12 |
Influenza, vaccinia, HSV, NDV, SeV, Dengue, West Nile, HIV-1 |
138, 139, 143, 146, 149, 153, 168
|
NKp30 (NCR3) |
3NOI |
B7H6, BAT3, HCMV pp65, heparan sulfate/hep arin, PfEMP-1 |
FcεRIγ, CD3ζ |
Influenza, vaccinia, HCV, HSV, HCMV, Ebola, Marburg |
140, 142–144, 146, 150–154, 169, 170
|
NKp80 |
--- |
Activation- induced C- type lectin |
AICL |
KSV |
163, 171
|
KIR2DS1 |
--- |
HLA- Cw2,4,5,6 (C2 epitope) |
DAP12 |
EBV |
15 |
KIR2DS2 |
1M4K |
--- |
DAP12 |
HCV, HSV-1 |
172, 173
|
KIR2DS4 |
3H8N |
HLA-Cw4 |
DAP12 |
HCV |
174–176
|
KIR3DS1 |
--- |
HLA-Bw4? |
DAP12 |
HIV |
42, 44, 49
|
KIR2DL4 |
3H8N |
HLA-G |
FceRIg, 1 ITIM |
|
177 |
|
inhibitory receptor |
structure |
ligand |
signaling |
virus |
references |
|
NKG2A/B- CD94 |
1B6E (CD94), 3BDW (CD94/NKG2A), 3CDG and 3CII (CD94/NKG2A/H LA-E) |
HLA-E |
1 ITIM |
HCMV, HIV-1, HCV |
88, 107, 112, 123, 178, 179, 180
|
KIR2DL1 |
1NKR, 1IM9 (KIR2DL1/HLA- Cw4) |
HLA- Cw2,4,5,6 (C2 epitope) |
2 ITIM |
EBV |
15, 60, 181
|
KIR2DL2 |
2DL1, 2DL2, 1EFX (KIR2DL2/HLA- Cw3) |
HLA- Cw1,3,7,8 (C1 epitope) |
2 ITIM |
HCV, HSV-1 |
61, 172, 182, 183
|
KIR2DL3 |
1B6U |
HLA- Cw1,3,7,8 (C1 epitope) |
2 ITIM |
HCV |
184, 36
|
KIR3DL1 |
3VH8 |
HLA-A, B (Bw4 epitope) |
2 ITIM |
HIV |
49, 63, 185
|
LILRB1 (ILT2) |
1UFU, 1VDJ, 1G0X, 1P7Q (LIR1/HLA-A2), 3D2U (LIR1/UL18) |
HLA class I, HLA-G, HLA-F, HLA-E, UL18 |
4 ITIM |
HCMV, HIV-1 |
75, 84, 85, 95
|
LILRB2 (ILT4) |
2GW5, 2DYP (LIR2/HLA-G) |
HLA class I, HLA-G, HLA-F, HLA-E, UL18 |
3 ITIM |
HCMV, HIV-1 |
75, 96, 99
|